Parkinson Medications

Parkinson Medications A new drug developed to treat Parkinson’s disease showed promising results in people with mild cognitive impairment (MCI) and mild dementia due to Alzheimer’s disease. Sage Therapeutics, Inc., a biopharmaceutical company, reported that the treatment was generally well-tolerated by participants in Phase 2 of its LUMINARY clinical trial of the neuropsychiatric drug candidate, … Continue reading “Parkinson Medications”